English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduScientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.
Tag: Medical Science
Scientists repurpose cancer and seizure medications to aid in the fight against COVID-19
Two teams of researchers using the Advanced Photon Source identified existing drugs — one used to treat cancer, the other an anti-seizure medication — that may work as treatments for COVID-19.
Exploiting cancer cells to aid in their own destruction
Researchers at the Pritzker School of Molecular Engineering at the University of Chicago have developed a new therapeutic vaccine that uses a patient’s own tumor cells to train their immune system to find and kill cancer.
Under wraps: X-rays reveal 1,900-year-old mummy’s secrets
Researchers used the powerful X-rays of the Advanced Photon Source to see the preserved remains of an ancient Egyptian girl without disturbing the linen wrappings. The results of those tests point to a new way to study mummified specimens.
Nanodevices for the brain could thwart formation of Alzheimer’s plaques
Researchers designed a nanodevice with the potential to prevent peptides from forming dangerous plaques in the brain in order to halt development of Alzheimer’s disease.
Argonne’s researchers and facilities playing a key role in the fight against COVID-19
Argonne scientists are working around the clock to analyze the virus to find new treatments and cures, predict how it will propagate through the population, and make sure that our supply chains remain intact.
Research at Argonne’s Advanced Photo Source Leads to New Ebola Drug
Scientists using specialized beamlines at Argonne’s Structural Biology Center (SBC), a facility for macromolecular crystallography at the Advanced Photon Source, derived insights that led to the discovery of a promising new drug for Ebola.
InnovationXLab Summit brings industry, national laboratories together around artificial intelligence
The recent InnovationXLab℠ Summit on AI raised the profile of the national laboratories’ work in AI and forged new partnerships between industry and the national labs.
CNS Gift to the CNS Foundation Doubles Innovative Clinical Research Initiative, Creating Annual NINDS/CNSF K12 Scholar Awards
The Congress of Neurological Surgeons Foundation (CNS Foundation) announced a second K12 award will be funded by a generous gift from the Congress of Neurological Surgeons (CNS). The award is made possible through a collaboration with the Foundation of the National Institutes of Health (FNIH) and the National Institutes of Health (NIH).
Congress of Neurological Surgeons Hosts 2019 Annual Meeting in San Francisco, October 19–23
Schaumburg, Illinois, August 21, 2019 — The Congress of Neurological Surgeons (CNS) is proud to host its 67th Annual Meeting in San Francisco, California, October 19–23. Each year, thousands of neurosurgeons, advanced practice providers, health care advocates, and other professionals from around the world gather to celebrate and learn about the advances are being made in the field of neurosurgery.